Requests · The University of Texas Rio Grande Valley School of Medicine
Restoration of the 3% Reductions
Priority 2 · one of 3 items in the The University of Texas Rio Grande Valley School of Medicine's request for 2028-29 · The item begins on page 68 of the request
This is a request, not an appropriation.
What is asked
| 2028 | 2029 | Two years | |
|---|---|---|---|
| All funds | $882,000 | $882,000 | $1,764,000 |
| Of which general revenue and general revenue-dedicated | $882,000 | $882,000 | $1,764,000 |
| Positions (full-time equivalents) | 8.2 | 8.2 |
How it would be financed
| Method of financing, as the request prints it | 2028 | 2029 |
|---|---|---|
| 1 General Revenue Fund | $882,000 | $882,000 |
| Total, as the request prints it | $882,000 | $882,000 |
Where it would land
The strategies this item would add to, numbered as the request numbers them, beside what each is appropriated in the current budget (2026-27 Act). One column is an appropriation and the other a request made on top of a base request not shown here, so the two are not subtracted.
| Strategy | Asked 2028 | Asked 2029 | Positions | Appropriated 2026 | Appropriated 2027 |
|---|---|---|---|---|---|
| 04-01-02 Cancer Center/Cancer Research | $882,000 | $882,000 | 8.2 | No strategy matched in the current budget | |
A strategy is matched by its name. Where none is matched, the strategy may be new, or may be in the current budget under a different name.
After 2029
| The agency's estimate | 2030 | 2031 | 2032 | Three years |
|---|---|---|---|---|
| All funds | $882,000 | $882,000 | $882,000 | $2,646,000 |
In the agency's words: Continued funding of ongoing program maintenance and administrative costs.
The agency's justification
The 3% reduction is being applied to the Cancer Center/Cancer Research non-formula support funding rather than to the School of Medicine and School of Podiatric Medicine items in order to maintain the operating funds essential for continued compliance with accreditation standards, supporting faculty and student success, and sustaining educational quality. While this approach preserves the institutional resources necessary to support accreditation readiness, the reduction will nonetheless affect the Cancer Center’s ability to expand research programs, recruit specialized oncology faculty and researchers, enhance clinical services, and advance development of the region’s first comprehensive academic Cancer Center. Accordingly, UTRGV respectfully requests restoration of the 3% cut to the base budget.
External and internal factors
Additional information is available in the Schedule 9 submission for Cervical Dysplasia and Cancer Immunology Center.
As marked in the request
- Has an information technology part: No
- Costs anticipated after the two budget years: Yes
- Involves contracts over $50,000: No